US Patent 9725449 Tricyclic compounds as anticancer agents
Patent 9725449 was granted and assigned to Bristol-Myers Squibb on August, 2017 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 10, 2016
Date of Patent
August 8, 2017
Patent Applicant
Patent Application Number
15150492
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9725449 Tricyclic compounds as anticancer agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
